Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate

Volume: 19 Number: 1 January 7, 2015
EN TR

Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate

Abstract

ABSTRACT
Poly (maleic anhydride-co-vinyl acetate) (MAVA) copolymer
was synthesized by free-radical- polymerization reaction in
methyl ethyl ketone (MEK) at 80 ºC using benzoyl-peroxide
(BPO) as the radical-initiator. MAVA was then modified with
anti-leukemic chemotherapy-agent cytosine β-Darabinofuranoside
hydrochloride (CF). Modification was
performed at 70 oC in dimethylformamide (DMF) containing
triethylamine (Et3N) as the catalyst. Structural characterization
of the copolymer and copolymer/drug couple (MAVA/CF) was
carried out by Fourier Transform Infrared (FTIR) and Nuclear
Magnetic Resonance (1H-NMR). FTIR and 1H-NMR spectra
confirmed the modification reaction. UV-Spectrophotometric
measurements indicated that MAVA/CF kept its molecular
integrity in physiological-body-fluid, PBS, for first four days.
Antiproliferative activities of MAVA/CF were also determined
by BrdU-cell-proliferation-ELISA assays using C6 and HeLa
cell lines (cisplatin and 5-fluorouracil used as positive control).
MAVA/CF appeared to have little antiproliferative activity
against C6 cell line while samples didn’t have antiproliferative
activity against HeLa cell line at low concentrations (< 100
μg/ml). Reaction mechanism was also recommended for
modification product MAVA/CF.
Keywords: Antiproliferative activity, copolymer modification,
cytosine β-D-arabinofuranoside hydrochloride, physiological
body fluid PBS, poly(maleic anhydride-co-vinyl acetate).

Keywords

References

  1. Saad GR, Morsi RE, Mohammady SZ, Elsabee MZ Dielectric relaxation of monoesters based poly(styrene-co-maleic anhydride) copolymer. J Polym Res 2008; 15:115-23
  2. Atıcı OG, Akar A, Rahimian R Modification of poly(maleic anhydride-co- styrene) with hydroxyl containing compounds. Turk J Chem 2001; 25:259-66.
  3. Patel H, Raval DA, Madamwar D, Patel SR Polymeric prodrug: Synthesis, release study and antimicrobial property of poly(styrene-co-maleic anhydride)-bound acriflavine. Angew Makromol Chem 1998; 263:25-30.
  4. Liu HY, Cao K, Yao Z, Li BG, Hu GH Variations of the glass- transition temperature in the imidization of poly(styrene-co- maleic anhydride). J Appl Polym Sci 2007; 104:2418-22
  5. Jain JP, Modi S, Domb AJ, Kumar N. Role of Polyanhydrides as localized Drug Carriers. Control Release 2005; 103:541- 63.
  6. Breslow DS Biologically active synthetic polymers. Pure & Appl Chem 1976; 46:103-13.
  7. Dhal PK, Holmes-Farley SR, Huval CC, Jozefiak TH. Polymers as drugs. Adv Polym Sci 2006;192:9-58.
  8. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003; 2:347-60.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Ayşe Şahin Yağlıoğlu This is me

Hacı Zengin This is me

Nihat Karakuş This is me

Publication Date

January 7, 2015

Submission Date

January 7, 2015

Acceptance Date

-

Published in Issue

Year 2015 Volume: 19 Number: 1

APA
Karakuş, G., Şahin Yağlıoğlu, A., Zengin, H., & Karakuş, N. (2015). Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate. Marmara Pharmaceutical Journal, 19(1), 73-81. https://doi.org/10.12991/mpj.2015198613
AMA
1.Karakuş G, Şahin Yağlıoğlu A, Zengin H, Karakuş N. Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate. J Res Pharm. 2015;19(1):73-81. doi:10.12991/mpj.2015198613
Chicago
Karakuş, Gülderen, Ayşe Şahin Yağlıoğlu, Hacı Zengin, and Nihat Karakuş. 2015. “Synthesis, Characterization and Antiproliferative Activities of Novel Modified Poly (maleic Anhydride-Co-Vinyl Acetate) Cytosine β-Darabinofuranoside Hydrochloride Conjugate”. Marmara Pharmaceutical Journal 19 (1): 73-81. https://doi.org/10.12991/mpj.2015198613.
EndNote
Karakuş G, Şahin Yağlıoğlu A, Zengin H, Karakuş N (January 1, 2015) Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate. Marmara Pharmaceutical Journal 19 1 73–81.
IEEE
[1]G. Karakuş, A. Şahin Yağlıoğlu, H. Zengin, and N. Karakuş, “Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate”, J Res Pharm, vol. 19, no. 1, pp. 73–81, Jan. 2015, doi: 10.12991/mpj.2015198613.
ISNAD
Karakuş, Gülderen - Şahin Yağlıoğlu, Ayşe - Zengin, Hacı - Karakuş, Nihat. “Synthesis, Characterization and Antiproliferative Activities of Novel Modified Poly (maleic Anhydride-Co-Vinyl Acetate) Cytosine β-Darabinofuranoside Hydrochloride Conjugate”. Marmara Pharmaceutical Journal 19/1 (January 1, 2015): 73-81. https://doi.org/10.12991/mpj.2015198613.
JAMA
1.Karakuş G, Şahin Yağlıoğlu A, Zengin H, Karakuş N. Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate. J Res Pharm. 2015;19:73–81.
MLA
Karakuş, Gülderen, et al. “Synthesis, Characterization and Antiproliferative Activities of Novel Modified Poly (maleic Anhydride-Co-Vinyl Acetate) Cytosine β-Darabinofuranoside Hydrochloride Conjugate”. Marmara Pharmaceutical Journal, vol. 19, no. 1, Jan. 2015, pp. 73-81, doi:10.12991/mpj.2015198613.
Vancouver
1.Gülderen Karakuş, Ayşe Şahin Yağlıoğlu, Hacı Zengin, Nihat Karakuş. Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)/cytosine β-Darabinofuranoside hydrochloride conjugate. J Res Pharm. 2015 Jan. 1;19(1):73-81. doi:10.12991/mpj.2015198613

.